View in EDS HTML Full Text PDF Full Text

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy.

Saved in:
Bibliographic Details
Title: Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy.
Authors: Cui, Hao1,2 (AUTHOR), Shu, Songren1,3 (AUTHOR), Zhang, Ningning1 (AUTHOR), Wang, Mangyuan1 (AUTHOR), Yang, Tianshuo1 (AUTHOR), Wang, Zhen1 (AUTHOR), Chen, Xiao1,2 (AUTHOR), Fu, Mengxia1,4 (AUTHOR), Xu, Mengda1,3 (AUTHOR), Yang, Yicheng1,5 (AUTHOR), Wang, Peizhi1,6,7 (AUTHOR), Wang, Chuangshi8 (AUTHOR), Yang, Qiaoxi1 (AUTHOR), Gao, Huimin1 (AUTHOR), Jiang, Yao1 (AUTHOR), Song, Jiangping1,2,3,9,10 (AUTHOR) fwsongjiangping@126.com
Source: BMC Medicine. 4/14/2025, Vol. 23 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17417015
DOI:10.1186/s12916-025-04024-y